Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.
2.

Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.

McNeill SA, Hargreave TB, Roehrborn CG; Alfaur study group.

Urology. 2005 Jan;65(1):83-9; discussion 89-90.

PMID:
15667868
3.

Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia.

Tiong HY, Tibung MJ, Macalalag M, Li MK, Consigliere D.

Urol Int. 2009;83(1):44-8. doi: 10.1159/000224867. Epub 2009 Jul 27.

PMID:
19641358
4.

The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.

Desgrandchamps F, De La Taille A, Doublet JD; RetenFrance Study Group.

BJU Int. 2006 Apr;97(4):727-33.

5.

Does acute urinary retention respond to alpha-blockers alone?

McNeill SA.

Eur Urol. 2001 Mar;39 Suppl 6:7-12. Review.

PMID:
11306895
6.

Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention.

McNeill SA, Hargreave TB; Members of the Alfaur Study Group.

J Urol. 2004 Jun;171(6 Pt 1):2316-20.

PMID:
15126812
7.

Prostate size influences the outcome after presenting with acute urinary retention.

McNeill AS, Rizvi S, Byrne DJ.

BJU Int. 2004 Sep;94(4):559-62.

9.

Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, placebo-controlled.

McNeill SA, Daruwala PD, Mitchell ID, Shearer MG, Hargreave TB.

BJU Int. 1999 Oct;84(6):622-7.

PMID:
10510105
10.
11.

Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily.

Emberton M, Elhilali M, Matzkin H, Harving N, van Moorselaar J, Hartung R, Alcaraz A, Vallancien G; Alf-One Study Group.

Urology. 2005 Aug;66(2):316-22.

PMID:
16098361
12.

Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia.

Fitzpatrick JM, Desgrandchamps F, Adjali K, Gomez Guerra L, Hong SJ, El Khalid S, Ratana-Olarn K; Reten-World Study Group.

BJU Int. 2012 Jan;109(1):88-95. doi: 10.1111/j.1464-410X.2011.10430.x. Epub 2011 Nov 25.

13.

[Alpha-adrenergic blockers as a support in the treatment of acute urinary retention].

Altarac S.

Lijec Vjesn. 2006 Jul-Aug;128(7-8):233-7. Review. Croatian.

PMID:
17087140
14.

Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.

Vallancien G, Emberton M, Alcaraz A, Matzkin H, van Moorselaar RJ, Hartung R, Harving N, Elhilali M; ALF-ONE Study Group.

BJU Int. 2008 Apr;101(7):847-52. doi: 10.1111/j.1464-410X.2008.07458.x.

15.

Randomised, placebo controlled, double blind study of alfuzosin SR in patients undergoing trial without catheter following acute urinary retention.

Shah T, Palit V, Biyani S, Elmasry Y, Puri R, Flannigan GM.

Eur Urol. 2002 Oct;42(4):329-32; discussion 332.

PMID:
12361896
16.

Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.

Emberton M, Lukacs B, Matzkin H, Alcaraz A, Elhilali M, Vallancien G.

J Urol. 2006 Sep;176(3):1051-6.

PMID:
16890690
17.

A comparative study on the use of tamsulosin versus alfuzosin in spontaneous micturition recovery after transurethral catheter removal in patients with benign prostatic growth.

Maldonado-Ávila M, Manzanilla-García HA, Sierra-Ramírez JA, Carrillo-Ruiz JD, González-Valle JC, Rosas-Nava E, Guzman-Esquivel J, Labra-Salgado IR.

Int Urol Nephrol. 2014 Apr;46(4):687-90. doi: 10.1007/s11255-013-0515-y. Epub 2013 Sep 24.

PMID:
24061764
18.
19.

The Reten-World survey of the management of acute urinary retention: preliminary results.

Emberton M, Fitzpatrick JM.

BJU Int. 2008 Mar;101 Suppl 3:27-32. doi: 10.1111/j.1464-410X.2008.07491.x. Review.

20.

Management of acute urinary retention secondary to benign prostatic hyperplasia in the UK: a national survey.

Manikandan R, Srirangam SJ, O'Reilly PH, Collins GN.

BJU Int. 2004 Jan;93(1):84-8.

PMID:
14678374

Supplemental Content

Support Center